Human medicines European public assessment report (EPAR): Praxbind, idarucizumab, Date of authorisation: 20/11/2015, Revision: 13, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 21 November 2024 - 11:53

Human medicines European public assessment report (EPAR): Praxbind, idarucizumab, Date of authorisation: 20/11/2015, Revision: 13, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/praxbind

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters